Literature DB >> 10602945

MR imaging of the chest: mediastinum and chest wall.

P Landwehr1, O Schulte, K Lackner.   

Abstract

This review presents the options and limitations of MRI in non-vascular diseases of the mediastinum and the chest wall. In numerous thoracic pathologies, MRI is a useful supplement to spiral CT. This imaging procedure also allows a contrast-media-free differentiation of solid tumors and vascular lesions (e. g., aortic aneurysms). The advantages of MRI over CT are particularly useful when multiplanar tumor imaging is required prior to surgery to establish the exact spatial relationship between tumor and the other mediastinal structures. Primary indications for MRI in diseases of the mediastinum and chest wall are therefore: (a) tumors of the posterior mediastinum for determining their position in relation to the neural foramina and the spinal canal; (b) chest wall tumors; (c) preoperative multiplanar imaging of primary mediastinal tumors; and (d) contraindications against CT exams with iodine contrast media.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602945     DOI: 10.1007/s003300050917

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  8 in total

1.  Thoracic staging of non-small-cell lung cancer using integrated (18)F-FDG PET/MR imaging: diagnostic value of different MR sequences.

Authors:  Benedikt Schaarschmidt; Christian Buchbender; Benedikt Gomez; Christian Rubbert; Florian Hild; Jens Köhler; Johannes Grueneisen; Henning Reis; Verena Ruhlmann; Axel Wetter; Harald H Quick; Gerald Antoch; Philipp Heusch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-08       Impact factor: 9.236

2.  Detection of small pulmonary nodules in high-field MR at 3 T: evaluation of different pulse sequences using porcine lung explants.

Authors:  M Regier; S Kandel; M G Kaul; B Hoffmann; H Ittrich; P M Bansmann; J Kemper; C Nolte-Ernsting; M Heller; G Adam; J Biederer
Journal:  Eur Radiol       Date:  2006-09-30       Impact factor: 5.315

3.  Diffusion-weighted magnetic resonance imaging of thymoma: ability of the Apparent Diffusion Coefficient in predicting the World Health Organization (WHO) classification and the Masaoka-Koga staging system and its prognostic significance on disease-free survival.

Authors:  Adriano Massimiliano Priola; Sandro Massimo Priola; Maria Teresa Giraudo; Dario Gned; Alessandro Fornari; Bruno Ferrero; Lorena Ducco; Andrea Veltri
Journal:  Eur Radiol       Date:  2015-10-01       Impact factor: 5.315

4.  Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to 18F-FDG PET/CT?

Authors:  Benedikt M Schaarschmidt; Johannes Grueneisen; Martin Metzenmacher; Benedikt Gomez; Thomas Gauler; Christian Roesel; Philipp Heusch; Verena Ruhlmann; Lale Umutlu; Gerald Antoch; Christian Buchbender
Journal:  Eur Radiol       Date:  2016-05-14       Impact factor: 5.315

5.  The role of positron emission tomography/computed tomography in the evaluation of anterior mediastinal masses and differentiating between the histological subtypes of thymic epithelial neoplasms.

Authors:  Ahmet Yanarateş; Emine Budak
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-03-06       Impact factor: 0.332

6.  Ventilation and perfusion magnetic resonance imaging of the lung.

Authors:  Grzegorz Bauman; Monika Eichinger
Journal:  Pol J Radiol       Date:  2012-01

7.  Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.

Authors:  Benedikt Michael Schaarschmidt; Christian Buchbender; Felix Nensa; Johannes Grueneisen; Johannes Grueneien; Benedikt Gomez; Jens Köhler; Henning Reis; Verena Ruhlmann; Lale Umutlu; Philipp Heusch
Journal:  PLoS One       Date:  2015-01-09       Impact factor: 3.240

8.  Assessment of Mediastinal Tumors Using SUVmax and Volumetric Parameters on FDG-PET/CT.

Authors:  Takahiro Morita; Mitsuaki Tatsumi; Mana Ishibashi; Kayako Isohashi; Hiroki Kato; Osamu Honda; Eku Shimosegawa; Noriyuki Tomiyama; Jun Hatazawa
Journal:  Asia Ocean J Nucl Med Biol       Date:  2017
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.